BridgeBio Pharma

Senior Director, Health Economics and Outcomes Research, International

BridgeBio Pharma · Switzerland Office

Posted about 3 months ago

or apply directly on BridgeBio Pharma's site. We never take the application ourselves.

Is this posting real?

This role has been open
81 days
BridgeBio Pharma's roles stay open a median of 82 days
Reposted
No
Salary listed
No
0% of BridgeBio Pharma's roles list one
Ghost-job risk at BridgeBio Pharma
high
81 stale, 1 reposted of 81 open
Hiring momentum
143 roles opened in the last 90 days
↑ up vs. the prior 90 days
Last confirmed on the employer's board
2026-10-24

Measured from postings appearing on and disappearing from BridgeBio Pharma's own greenhouse board since 2026-08-03. Full hiring picture for BridgeBio Pharma.

About this role

In this role, you will lead the international health economics and outcomes research (HEOR) strategy at BridgeBio, focusing on generating evidence to secure patient access to innovative therapies. You will oversee HTA submissions, manage real-world evidence studies, and collaborate with various teams to align HEOR priorities with market access strategies. Your work will involve engaging with key HTA bodies and managing external vendors to ensure project success across multiple international markets.

Our read on this posting2.4out of 5
benefits
2/5
freshness
1/5
career value
4/5
role clarity
5/5
pay transparency
0/5

Scored from the posting itself — how clearly the role is described, how much it says about pay and benefits, and how recently it was listed. Not a judgement of BridgeBio Pharma as an employer.

What you need

  • Graduate degree in health economics, epidemiology, health services research, or another research-focused public health field (PhD preferred)
  • 9+ years of experience with an MSc/MPH, or 7+ years with a PhD, in HEOR or related fields
  • Extensive experience leading HTA submissions and pricing negotiations across multiple international markets, ideally including Europe
  • Direct experience engaging with HTA organizations such as NICE, CADTH, PBAC, HAS, IQWiG/G-BA, and ICER
  • Demonstrated in-depth understanding of health economic modeling, patient-reported outcomes, statistics, and real-world evidence studies
  • Capable of independently managing complex, multicultural, cross-functional teams and non-interventional study projects on an international basis

What you get

  • Market leading compensation
  • Hybrid work model
  • Career development through regular feedback, continuous education and professional development programs
  • Financial rewards, peer-to-peer recognition, and growth opportunities

Worth weighing

  • No specific salary listed
  • Position requires in-office presence
  • Role involves significant collaboration across multiple international markets
  • Focus on rare diseases and orphan conditions may limit broader experience

Summarised from BridgeBio Pharma's posting. Read the full original.

Listed by BridgeBio Pharma on their greenhouse job board, last confirmed open on 2026-10-24. PitchMeAI is not the employer.

More roles at BridgeBio Pharma

All 81 open roles at BridgeBio Pharma →